» Articles » PMID: 11156817

Sex Differences in Extrastriatal Dopamine D(2)-like Receptors in the Human Brain

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 2001 Feb 7
PMID 11156817
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The study examined gender differences in extrastriatal dopamine D2-like receptor levels in the human brain in vivo.

Method: [(11)C]FLB 457, a high-affinity radioligand for extrastriatal D(2)-like receptors, and a three-dimensional positron emission tomography system were used to measure D(2)-like receptor binding potentials in frontal cortex, temporal cortex, and thalamus in 12 healthy men and 12 healthy women.

Results: Women had higher D(2)-like receptor binding potentials than men in the three brain regions studied, and the difference in the frontal cortex was statistically significant. In a more detailed regional analysis, the difference between the sexes was most pronounced for the left and right anterior cingulate cortex.

Conclusions: This study provides in vivo evidence for a gender difference in dopamine D(2)-like receptor levels, which could be reflected in gender-associated differences in clinical disorders linked to the dopamine system.

Citing Articles

Protection from oxygen-glucose deprivation by neurosteroid treatment in primary neurons and oligodendrocytes.

Moloney R, Pavy C, Kahl R, Palliser H, Hirst J, Shaw J In Vitro Cell Dev Biol Anim. 2024; 60(9):1068-1084.

PMID: 39075243 PMC: 11534971. DOI: 10.1007/s11626-024-00957-5.


Sexual dimorphism in histamine regulation of striatal dopamine.

Van Zandt M, Pittenger C bioRxiv. 2024; .

PMID: 38826392 PMC: 11142073. DOI: 10.1101/2024.05.20.595049.


Exploring sex differences: insights into gene expression, neuroanatomy, neurochemistry, cognition, and pathology.

Lafta M, Mwinyi J, Affatato O, Rukh G, Dang J, Andersson G Front Neurosci. 2024; 18:1340108.

PMID: 38449735 PMC: 10915038. DOI: 10.3389/fnins.2024.1340108.


Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors.

Hersey M, Bartole M, Jones C, Newman A, Tanda G Molecules. 2023; 28(13).

PMID: 37446929 PMC: 10343811. DOI: 10.3390/molecules28135270.


The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats.

Chellian R, Behnood-Rod A, Wilson R, Lin K, King G, Bruijnzeel A J Psychopharmacol. 2023; 37(2):216-228.

PMID: 36680471 PMC: 10704414. DOI: 10.1177/02698811221147141.